If you are:
Absolute Contraindication: CONTRAINDICATED PER MFR;EXCRETED IN RAT STUDIES,POTENTIAL SEV ADVERSE EFFECTS
An adult over 60:
management or monitoring precaution: Renal-Higher incidence of myopathy or rhabdomyolysis particularly with renal disease. Use with caution for CLCr < 30mL/minute. Hepatic-Obtain LFTs before the initiation of treatment, at 6 and 12 weeks after initiation of therapy or elevation of dose, and periodically thereafter (e.g., semiannually).
Giving lovastatin Tablet, Extended Release 24 hr to a child under 12:
management or monitoring precaution: Manufacturer recommends post-menarche females be counseled on appropriate contraception. Monitor for myopathy, liver function.
management or monitoring precaution: Not studied in prepubertal girls or patients less than 10 years of age.